HON

HON Financing Cash Flow

-$4.78BTTM · USD

Period ending:

HON FY Cash from FinancingUSD
HON FY Cash from Financing1989-12-31: -$380.00M1990-12-31: -$417.00M1991-12-31: -$172.00M1992-12-31: -$649.00M1993-12-31: -$400.00M1994-12-31: -$555.00M1995-12-31: -$80.00M1996-12-31: -$544.00M1997-12-31: -$877.00M1998-12-31: -$15.00M1999-12-31: -$1.11B2000-12-31: -$70.00M2001-12-31: -$893.00M2002-12-31: -$882.00M2003-12-31: -$895.00M2004-12-31: -$1.22B2005-12-31: -$2.72B2006-12-31: -$2.65B2007-12-31: -$1.57B2008-12-31: -$1.37B2009-12-31: -$2.15B2010-12-31: -$2.05B2011-12-31: -$1.11B2012-12-31: -$1.21B2013-12-31: -$433.00M2014-12-31: -$2.27B2015-12-31: $102.00M2016-12-31: $346.00M2017-12-31: -$3.52B2018-12-31: -$5.03B2019-12-31: -$6.60B2020-12-31: -$81.00M2021-12-31: -$8.25B2022-12-31: -$6.33B2023-12-31: -$5.76B2024-12-31: $6.84B2025-12-31: -$1.95B$6.84B-$8.25B
1989-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

HON financing cash flow history

Cash from issuing/repaying debt and equity. The available annual fiscal periods series contains 37 observations from Dec 31, 1989 to Dec 31, 2025.

Honeywell Financing Cash Flow — Annual fiscal periods (USD)
Period endingFinancing Cash Flow (USD)
-1,953,000,000
6,839,000,000
-5,763,000,000
-6,330,000,000
-8,254,000,000
-81,000,000
-6,600,000,000
-5,032,000,000
-3,516,000,000
346,000,000
102,000,000
-2,272,000,000
-433,000,000
-1,206,000,000
-1,114,000,000
-2,047,000,000
-2,152,000,000
-1,370,000,000
-1,574,000,000
-2,649,000,000
-2,716,000,000
-1,223,000,000
-895,000,000
-882,000,000
-893,000,000
-70,000,000
-1,110,000,000
-15,000,000
-877,000,000
-544,000,000
-80,000,000
-555,000,000
-400,000,000
-649,000,000
-172,000,000
-417,000,000
-380,000,000

Compare financing cash flow

All HON financial metrics · HON stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.